Colchicine – Page 10 – Communicable Diseases Research

Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications

Special Article

Published on 2021-05-252022-10-31
Journal: European Geriatric Medicine [Category] COVID-19, MERS, SARS,

Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents

Review

Published on 2021-05-042022-10-29
Journal: Pediatric Rheumatology Online Journal [Category] COVID-19,

[키워드] administration Adults Anakinra anti-IL-1 anti-IL-6 approach biologic agents canakinumab caused children Chloroquine clinical experience Colchicine condition contributing to coronavirus COVID-19 Cytokine storm defined develop disease course disease phenotype disease stage drug drugs dysregulation Evidence expression Hydroxychloroquine immune immune system impairment induce Inflammatory inflammatory mediator less macrophage activation syndrome manifestation Mild MIS-C multisystem inflammatory syndrome in children pediatric Pediatric patients pharmacological representing resulting role SARS-CoV-2 severe coronavirus disease severe disease supported syndrome systemic manifestation the disease the timing Therapeutic approach Tocilizumab Treatment
[DOI] 10.1186/s12969-021-00559-5 PMC 바로가기 [Article Type] Review

Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends

Article

Published on 2021-05-012023-07-05
Journal: Clinical Rheumatology [Category] SARS,

[키워드] Anakinra Colchicine Google search Hydroxychloroquine Internet Tocilizumab
[DOI] 10.1007/s10067-020-05490-w PMC 바로가기

Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline

코로나바이러스 질환 2019(COVID-19)로 입원한 성인 관리: 유럽 호흡기 학회 생활 지침

Practice Guideline

Published on 2021-04-152022-09-11
Journal: The European Respiratory Journal [Category] Fulltext, MERS, meta-analysis,

[키워드] anticoagulation approach Azithromycin Care Chinese Colchicine Continuous Positive Airway Pressure coronavirus disease Coronavirus disease 2019 Corticosteroids COVID-19 European Evidence high mortality rate High-flow nasal oxygen hospitalised Hospitalised patients Hydroxychloroquine hypoxaemic respiratory failure IMPROVE initial interleukin Intervention Invasive mechanical ventilation invasive ventilation literature review Lopinavir Lopinavir-ritonavir management Meta-analysis monoclonal antibody treatment noninvasive respiratory Optimising outcome outcomes oxygen Patient performed pharmacological PICO positive airway pressure receptor receptor antagonist recommendation recommendations Remdesivir requiring supplemental oxygen Research respiratory Respiratory failure Ritonavir SARS-COV-2 infection Society strength supplemental oxygen supplementary oxygen Support systemic corticosteroid systemic corticosteroids Task Force use of hydroxychloroquine ventilatory support was used were used
[DOI] 10.1183/13993003.00048-2021 PMC 바로가기 [Article Type] Practice Guideline

Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation

Research

Published on 2021-04-122022-10-05
Journal: Nature metabolism [Category] 바이오마커, 신약개발,

COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study

가족성 지중해열 환자의 COVID-19 결과: 후향적 코호트 연구

Article

Published on 2021-04-012022-09-11
Journal: Rheumatology International [Category] SARS, 치료기술,

[키워드] acute respiratory syndrome Admission Chain Reaction Cohort Colchicine colchicine treatment collected comorbid disease comorbid diseases Comorbidity coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 Diagnosis died evaluated Familial Familial Mediterranean fever Fever Frequency hospital Hospital stay hospitalisation Hospitalized hospitalized patients IL-1 information inhibitor intensive care intensive care unit intensive care unit admission interleukin interleukin (IL)-1 medical records Mediterranean Mediterranean fever Mortality outcome Patient patients patients hospitalized PCR PCR test polymerized positive retrospective cohort retrospective cohort study SARS-CoV 2 test result Treatment
[DOI] 10.1007/s00296-021-04812-8 PMC 바로가기 [Article Type] Article

Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects

Research article

Published on 2021-04-012022-10-05
Journal: Pulmonary pharmacology & therapeutics [Category] SARS, 바이오마커,

[키워드] ACE2 acute lung injury acute respiratory distress acute respiratory syndrome addition ARDS attenuate caused clinical outcomes clinical study Colchicine Combination combination therapy complications coronavirus COVID-19 COVID-19 severity Cytokine storm Dipeptidyl peptidase 4 disease severity doxycycline DPP4 Effect enzyme evaluate exaggerated immune response expressed FIVE global pandemic immune immune response improvement Infection Laboratory lung observation outcome outcomes pathogenesis of SARS-CoV-2 patients with COVID-19 Pneumonia Prospective Study radiological Randomized reduction regimen required SARS-CoV-2 Symptom syndrome the patient therapeutic therapy treat viral infectious disease Viral load Virus Disease
[DOI] 10.1016/j.pupt.2021.102008 [Article Type] Research article

Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study

콜히친으로 치료받은 COVID-19 환자의 사망률 감소: 후향적 관찰 연구 결과

Observational Study

Published on 2021-03-242022-08-13
Journal: PLoS ONE [Category] Biochemistry, SARS, 임상,

[키워드] 7-point ordinary scale accelerated adjusted adjusted hazard ratio association C-reactive protein Clinical improvement Colchicine colchicine group control group control patient control patients coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients CT scan cumulative mortality diarrhea Hospitalized implicated IMPROVE Inflammatory marker inflammatory markers Inflammatory response linear lymphocyte Lymphocyte count Mortality neutrophil Neutrophil-to-lymphocyte ratio objective occurred outpatients pathway patients Pneumonia Probability proinflammatory pulmonary complications Randomized controlled trial rationale receive reduce reduced Result retrospective retrospective cohort study Retrospective study Side effect skin rashes Support supported survival the patient treated Treatment two groups Weighting
[DOI] 10.1371/journal.pone.0248276 PMC 바로가기 [Article Type] Observational Study

Potential COVID‐19 Therapeutic Agents and Vaccines: An Evidence‐Based Review

Review

Published on 2021-03-052023-06-15
Journal: Journal of clinical pharmacology [Category] MERS, SARS,

[키워드] Baricitinib Colchicine convalescent plasma COVID‐19 Dexamethasone IFN‐β‐1a Methylprednisolone Remdesivir SARS‐CoV‐2 Tocilizumab
[DOI] 10.1002/jcph.1822 PMC 바로가기 [Article Type] Review

Challenges in Managing Pericardial Disease Related to Post Viral Syndrome After COVID-19 Infection

Cardiology

Published on 2021-02-202022-10-31
Journal: Cureus [Category] COVID-19,